Dexcom G6 is suitable for anyone with type 1 diabetes over the age of 2 years. Whether treated with multiple daily injections or insulin pump therapy, they can benefit from real-time continuous glucose monitoring (rt-CGM).
Who Can Benefit?
Adulti
Bambini e ragazzi
Donne in gravidanza
More Insight Than Monitoring Alone
Unlike a single reading from a blood glucose meter, rt-CGM provides dynamic information about the direction of glucose change, giving your patient continuous and timely feedback on nutrition, activity, and insulin requirements to help make informed diabetes treatment decisions. CGM is a powerful therapy management tool that can inform better diabetes treatment decisions, ultimately leading to tighter glycaemic control, than using a blood glucose meter alone.1
1 Pettus J, Price DA, Edelman SV. How Patients with Type 1 Diabetes Translate Continuous Glucose Monitoring Data into Diabetes Management Decisions. Endocr Pract. 2015;:1-25.